ameera-3: serd for er her2- breast cancer
Published 3 years ago • 1K plays • Length 1:51Download video MP4
Download video MP3
Similar videos
-
2:46
ameera-3: amcenestrant does not improve pfs in er /her2- breast cancer
-
4:40
ameera-1 updates: amcenestrant plus palbociclib for patients with er /her2– advanced breast cancer
-
1:25
ameera-5: amcenestrant palbociclib for previously untreated er /her2- advanced breast cancer
-
0:50
serds for patients with er /her2- breast cancer
-
2:35
ameera-6: amcenestrant, a novel serd, in hr breast cancer
-
2:35
what does the future hold for serds in er breast cancer?
-
3:44
alternate: neoadjuvant endocrine treatment in er /her2- breast cancer
-
0:30
the role of serds in the treatment landscape of patients with er /her2- breast cancer
-
0:52
first-line camizestrant for er /her2- advanced breast cancer
-
1:27
emerald: elacestrant vs physicians choice in er /her2- breast cancer
-
0:51
ember-2: preoperative imlunestrant for er /her2- early stage breast cancer
-
4:39
serd vs investigator’s choice of endocrine monotherapy for er /her2-advanced/mbc
-
57:18
navigating the expanding treatment arsenal for er /her2- breast cancer
-
2:05
important considerations in the management of hr , her2-negative early breast cancer
-
1:39
clinical trials for stage ii-iii breast cancer
-
3:01
alternate: neoadjuvant chemotherapy in er her2- breast cancer
-
2:03
emerald: elacestrant vs. soc for patients with er her2- metastatic breast cancer
-
0:31
remaining questions regarding her2-low breast cancer
-
1:21
advantages of metronomic chemotherapy in er /her2- metastatic breast cancer